Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.32 trillion and total revenue of $123.1 billion.
Market Cap
1.32T
Revenue
123.1B
Profits
-32.5B
PE Ratio
n/a
Profit Margin
-26.40%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.49B | 0.69% | 542,986 | 12.95B |
| 2 | MRNA | Moderna, Inc. | 105.60B | 9.54% | 13,379,224 | 2.53B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 91.18B | 0.63% | 494,471 | 16.90B |
| 4 | ARGX | argenx SE | 58.44B | 2.73% | 248,509 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 46.64B | 5.43% | 679,893 | 6.61B |
| 6 | RVMD | Revolution Medicines, Inc. | 41.82B | 8.83% | 2,805,571 | 197.56M |
| 7 | RPRX | Royalty Pharma plc | 38.45B | -0.78% | 1,957,278 | 2.62B |
| 8 | GMAB | Genmab A/S | 34.93B | 1.12% | 6,399,685 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.09B | 6.20% | 6,725,109 | 7.53M |
| 10 | INSM | Insmed Incorporated | 24.49B | 2.66% | 1,597,179 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.27B | 0.90% | 629,358 | 6.01B |
| 12 | BNTX | BioNTech SE | 21.73B | 2.07% | 441,997 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.87B | -0.54% | 1,583,842 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 17.00B | 1.38% | 1,099,984 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.94B | 1.77% | 422,826 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.09B | 3.44% | 437,239 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.43B | -0.24% | 1,472,027 | 945.54M |
| 18 | SMMT | Summit Therapeutics Inc. | 12.77B | 12.54% | 3,784,312 | - |
| 19 | HALO | Halozyme Therapeutics, Inc. | 11.78B | -15.60% | 4,419,321 | 1.80B |
| 20 | TECH | Bio-Techne Corporation | 11.41B | 0.12% | 1,392,747 | 1.22B |
| 21 | KYMR | Kymera Therapeutics, Inc. | 11.21B | 2.51% | 443,655 | 102.24M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.77B | -0.91% | 1,594,861 | 3.66B |
| 23 | PCVX | Vaxcyte, Inc. | 10.20B | 4.10% | 1,224,630 | - |
| 24 | SYRE | Spyre Therapeutics, Inc. | 9.77B | 6.47% | 689,229 | - |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.17B | -1.36% | 850,416 | 1.43B |
| 26 | IBRX | ImmunityBio, Inc. | 9.04B | 6.49% | 5,880,528 | 165.79M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.95B | 0.55% | 104,772 | 470.03M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 8.66B | -1.08% | 654,940 | 551.69M |
| 29 | TGTX | TG Therapeutics, Inc. | 8.50B | 3.31% | 1,202,712 | 799.54M |
| 30 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.17B | 0.66% | 838,885 | 669.50M |
| 31 | CORT | Corcept Therapeutics Incorporated | 7.93B | 1.21% | 722,799 | 963.65M |
| 32 | ABVX | ABIVAX Société Anonyme | 7.79B | 2.56% | 515,259 | 5.33M |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 7.68B | 4.78% | 157,719 | 7.46M |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.67B | 5.41% | 3,927,986 | 280.75M |
| 35 | CYTK | Cytokinetics, Incorporated | 7.60B | -1.59% | 1,353,887 | 113.29M |
| 36 | TWST | Twist Bioscience Corporation | 7.45B | -1.51% | 1,408,588 | 431.80M |
| 37 | CAI | Caris Life Sciences, Inc. | 7.28B | -2.54% | 6,975,823 | 1.05B |
| 38 | AXSM | Axsome Therapeutics, Inc. | 7.00B | 2.53% | 403,558 | 865.27M |
| 39 | ORKA | Oruka Therapeutics, Inc. | 6.76B | 6.31% | 646,496 | - |
| 40 | CGON | CG Oncology, Inc. | 6.63B | 15.42% | 2,169,662 | 6.17M |
| 41 | IONS | Ionis Pharmaceuticals, Inc. | 6.59B | 2.19% | 1,095,263 | 874.09M |
| 42 | IMVT | Immunovant, Inc. | 6.25B | 6.55% | 1,674,751 | - |
| 43 | KOD | Kodiak Sciences Inc. | 6.22B | 8.99% | 413,284 | - |
| 44 | BLTE | Belite Bio, Inc | 6.20B | 7.55% | 131,919 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 6.19B | 1.33% | 490,494 | 670.78M |
| 46 | LGND | Ligand Pharmaceuticals Incorporated | 6.12B | 2.30% | 59,485 | 253.83M |
| 47 | MANE | Veradermics, Incorporated | 5.84B | 8.69% | 309,038 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.73B | 3.41% | 937,885 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.49B | 0.14% | 388,688 | 1.16B |
| 50 | COGT | Cogent Biosciences, Inc. | 5.42B | 5.58% | 774,774 | - |
| 51 | EWTX | Edgewise Therapeutics, Inc. | 4.94B | 16.08% | 2,362,916 | - |
| 52 | ERAS | Erasca, Inc. | 4.88B | 5.20% | 2,062,048 | - |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.84B | 3.61% | 382,405 | 2.72M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.84B | 2.72% | 752,406 | 25.17M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.79B | 2.01% | 579,344 | 651.03M |
| 56 | LEGN | Legend Biotech Corporation | 4.51B | 3.35% | 1,139,740 | 1.27B |
| 57 | DFTX | Definium Therapeutics, Inc. | 4.43B | 8.63% | 756,159 | - |
| 58 | RLAY | Relay Therapeutics, Inc. | 4.04B | 8.35% | 1,724,200 | 10.35M |
| 59 | ABCL | AbCellera Biologics Inc. | 3.82B | 5.93% | 1,420,167 | 66.17M |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 3.76B | 2.99% | 402,746 | 7.50M |
| 61 | IOVA | Iovance Biotherapeutics, Inc. | 3.70B | 5.43% | 8,103,435 | 378.98M |
| 62 | ACAD | Acadia Pharmaceuticals Inc. | 3.67B | -0.05% | 865,166 | 1.20B |
| 63 | TNGX | Tango Therapeutics, Inc. | 3.65B | 3.64% | 800,145 | 53.81M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 3.60B | 9.65% | 594,889 | - |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.54B | 2.80% | 410,455 | 148.00K |
| 66 | IRON | Disc Medicine, Inc. | 3.49B | 0.17% | 317,205 | - |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.42B | 3.96% | 1,778,199 | - |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.40B | 5.01% | 1,243,616 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.32B | -0.20% | 312,045 | 682.20M |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.30B | 2.23% | 271,342 | 890.79M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.27B | 0.95% | 3,066,810 | 26.31M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.24B | 2.38% | 871,711 | 21.38M |
| 73 | CELC | Celcuity Inc. | 3.23B | 3.11% | 597,029 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 3.22B | -5.56% | 2,061,424 | 508.68M |
| 75 | ZLAB | Zai Lab Limited | 3.16B | 12.52% | 1,391,563 | 441.73M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.97B | 0.36% | 829,902 | 36.54M |
| 77 | ADMA | ADMA Biologics, Inc. | 2.87B | -2.16% | 2,821,223 | 519.15M |
| 78 | VCEL | Vericel Corporation | 2.77B | 4.55% | 954,012 | 324.17M |
| 79 | XNCR | Xencor, Inc. | 2.71B | 6.18% | 634,659 | 200.49M |
| 80 | RCUS | Arcus Biosciences, Inc. | 2.66B | 4.52% | 447,564 | 100.00M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.62B | 1.55% | 1,393,542 | 146.64M |
| 82 | PVLA | Palvella Therapeutics, Inc. | 2.52B | 11.58% | 348,371 | - |
| 83 | PHVS | Pharvaris N.V. | 2.45B | 7.21% | 215,318 | - |
| 84 | MBX | MBX Biosciences, Inc. | 2.44B | 4.66% | 304,577 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.36B | 6.08% | 515,571 | 158.00K |
| 86 | SEPN | Septerna, Inc. | 2.31B | 4.63% | 165,348 | 98.88M |
| 87 | COAG | Hemab Therapeutics Holdings, Inc. | 2.28B | 7.24% | 263,709 | - |
| 88 | NAMS | NewAmsterdam Pharma Company N.V. | 2.28B | 0.85% | 817,251 | 25.94M |
| 89 | RXRX | Recursion Pharmaceuticals, Inc. | 2.23B | 2.00% | 10,286,041 | 68.23M |
| 90 | IMNM | Immunome, Inc. | 2.22B | 5.25% | 792,480 | 4.02M |
| 91 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | 1.23% | 689,806 | 321.74M |
| 92 | BHVN | Biohaven Ltd. | 2.16B | 3.09% | 834,977 | - |
| 93 | LKFT | Lakefront Biotherapeutics NV | 2.16B | -0.60% | 263,182 | 1.13B |
| 94 | VERA | Vera Therapeutics, Inc. | 2.15B | -1.26% | 1,358,124 | 10.28M |
| 95 | ZYME | Zymeworks Inc. | 2.11B | 3.29% | 611,794 | 37.13M |
| 96 | FTRE | Fortrea Holdings Inc. | 2.10B | 6.55% | 1,040,756 | 2.67B |
| 97 | VIR | Vir Biotechnology, Inc. | 2.09B | 10.75% | 945,720 | 302.80M |
| 98 | REPL | Replimune Group, Inc. | 2.02B | 6.24% | 1,577,321 | - |
| 99 | TRVI | Trevi Therapeutics, Inc. | 2.00B | 9.52% | 1,586,067 | - |
| 100 | TRAX | First Tracks Biotherapeutics, Inc. | 1.99B | 4.45% | 289,979 | - |
| 101 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.94B | 7.31% | 1,055,891 | 213.00M |
| 102 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 1.76% | 390,676 | 989.36M |
| 103 | MAZE | Maze Therapeutics, Inc. | 1.86B | 6.06% | 308,143 | 20.00M |
| 104 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | 0.14% | 1,635,170 | 1.96B |
| 105 | ZBIO | Zenas BioPharma, Inc. | 1.85B | 9.26% | 306,184 | 11.00M |
| 106 | MESO | Mesoblast Limited | 1.83B | 1.21% | 162,537 | 120.25M |
| 107 | NVAX | Novavax, Inc. | 1.78B | 10.48% | 4,136,292 | 411.65M |
| 108 | ABSI | Absci Corporation | 1.75B | 8.41% | 2,996,930 | 1.56M |
| 109 | AGIO | Agios Pharmaceuticals, Inc. | 1.74B | 3.08% | 683,974 | 140.84M |
| 110 | STOK | Stoke Therapeutics, Inc. | 1.73B | 1.61% | 595,680 | 28.21M |
| 111 | LYCA | Lycia Therapeutics, Inc. | 1.72B | 3.58% | 305,768 | 4.44M |
| 112 | KLRA | Kailera Therapeutics, Inc. | 1.71B | 8.30% | 375,379 | - |
| 113 | GENB | Generate Biomedicines, Inc. | 1.68B | 4.14% | 387,531 | 26.48M |
| 114 | NRIX | Nurix Therapeutics, Inc. | 1.66B | 2.16% | 1,826,513 | 701.94M |
| 115 | SLS | SELLAS Life Sciences Group, Inc. | 1.65B | 3.81% | 6,135,181 | - |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.59B | 1.94% | 2,835,747 | 52.89M |
| 117 | RARE | Ultragenyx Pharmaceutical Inc. | 1.58B | -0.13% | 2,335,109 | 730.00M |
| 118 | IMCR | Immunocore Holdings plc | 1.57B | 7.04% | 1,120,976 | 430.78M |
| 119 | PGEN | Precigen, Inc. | 1.55B | 2.61% | 5,442,835 | 156.94M |
| 120 | NBTX | Nanobiotix S.A. | 1.55B | 1.32% | 113,271 | 13.15M |
| 121 | QURE | uniQure N.V. | 1.51B | 3.86% | 651,214 | 20.17M |
| 122 | BRVE | Braveheart Bio, Inc. | 1.51B | 6.23% | 511,489 | - |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.49B | 9.79% | 172,939 | - |
| 124 | NUVB | Nuvation Bio Inc. | 1.48B | 0.12% | 2,528,416 | 201.73M |
| 125 | GPCR | Structure Therapeutics Inc. | 1.47B | 8.12% | 1,218,188 | - |
| 126 | OCUL | Ocular Therapeutix, Inc. | 1.46B | 3.50% | 1,128,866 | 52.06M |
| 127 | TYRA | Tyra Biosciences, Inc. | 1.44B | 0.29% | 474,561 | - |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.43B | 1.81% | 464,255 | 20.00M |
| 129 | KARD | Kardigan, Inc. | 1.42B | 9.74% | 200,480 | - |
| 130 | TSHA | Taysha Gene Therapies, Inc. | 1.42B | 6.36% | 1,855,427 | 5.49M |
| 131 | ADRX | ADARx Pharmaceuticals, Inc. | 1.41B | -5.19% | 284,620 | 6.13M |
| 132 | KRSA | Korsana Biosciences, Inc. | 1.41B | 1.41% | 34,811 | - |
| 133 | ANAB | AnaptysBio, Inc. | 1.39B | 2.07% | 167,701 | 106.09M |
| 134 | AAPG | Ascentage Pharma Group International | 1.39B | 1.12% | 5,277 | 94.61M |
| 135 | INVA | Innoviva, Inc. | 1.37B | 0.47% | 881,640 | 438.32M |
| 136 | MLYS | Mineralys Therapeutics, Inc. | 1.36B | 0.85% | 622,358 | - |
| 137 | LBRX | LB Pharmaceuticals Inc | 1.33B | 8.35% | 240,812 | - |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.28B | 4.29% | 229,468 | - |
| 139 | NKTR | Nektar Therapeutics | 1.27B | 3.29% | 309,804 | 54.59M |
| 140 | GHRS | GH Research PLC | 1.27B | 0.54% | 329,978 | - |
| 141 | AVLN | Avalyn Pharma Inc. | 1.27B | 7.16% | 278,706 | - |
| 142 | MNKD | MannKind Corporation | 1.25B | 3.72% | 2,622,258 | 413.37M |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.23B | 4.43% | 129,499 | 1.30M |
| 144 | SVRA | Savara Inc. | 1.23B | 10.50% | 1,391,176 | - |
| 145 | OMER | Omeros Corporation | 1.22B | -0.94% | 599,676 | 38.42M |
| 146 | URGN | UroGen Pharma Ltd. | 1.22B | -3.03% | 1,265,749 | 250.25M |
| 147 | VOR | Vor Biopharma Inc. | 1.21B | 5.89% | 272,697 | - |
| 148 | SGP | SpyGlass Pharma, Inc. | 1.20B | 4.90% | 79,493 | - |
| 149 | SLN | Silence Therapeutics plc | 1.19B | 0.03% | 751,236 | 615.00K |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 4.76% | 113,647 | - |
| 151 | JANX | Janux Therapeutics, Inc. | 1.06B | 8.22% | 369,025 | 23.29M |
| 152 | VSTM | Verastem, Inc. | 1.01B | -11.19% | 5,033,454 | 100.30M |
| 153 | ANRO | Alto Neuroscience, Inc. | 973.99M | 13.49% | 395,734 | - |
| 154 | MLTX | MoonLake Immunotherapeutics | 972.77M | 5.83% | 668,905 | - |
| 155 | JBIO | Jade Biosciences, Inc. | 948.24M | 5.74% | 290,906 | - |
| 156 | ODTX | Odyssey Therapeutics, Inc. | 928.62M | 2.60% | 385,112 | 99.00K |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 916.81M | 4.18% | 252,905 | - |
| 158 | IVA | Inventiva S.A. | 912.97M | 1.93% | 1,301,931 | 2.81M |
| 159 | CTY | City Therapeutics, Inc. | 904.08M | 6.44% | 165,280 | 14.34M |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 900.06M | 2.93% | 424,609 | 70.33M |
| 161 | CRVS | Corvus Pharmaceuticals, Inc. | 890.84M | 8.84% | 729,421 | - |
| 162 | PHAR | Pharming Group N.V. | 884.35M | 0.49% | 9,083 | 386.75M |
| 163 | AKTS | Aktis Oncology, Inc. | 879.34M | 6.46% | 231,422 | 10.06M |
| 164 | MGTX | MeiraGTx Holdings plc | 862.47M | 5.52% | 419,939 | 397.50M |
| 165 | IMTX | Immatics N.V. | 861.15M | 1.94% | 462,249 | 47.65M |
| 166 | OBX | Obsidian Therapeutics, Inc. | 859.88M | 45.00% | 1,553,489 | - |
| 167 | SNDX | Syndax Pharmaceuticals, Inc. | 857.97M | 1.71% | 2,251,744 | 289.68M |
| 168 | LTGO | Latigo Biotherapeutics, Inc. | 853.94M | -1.00% | 303,870 | - |
| 169 | PRME | Prime Medicine, Inc. | 821.92M | 3.82% | 1,542,908 | 4.07M |
| 170 | LXRX | Lexicon Pharmaceuticals, Inc. | 805.37M | 12.42% | 2,398,995 | 38.54M |
| 171 | BBTX | Bambusa Therapeutics, Inc. | 801.83M | -0.69% | 124,597 | - |
| 172 | ANNX | Annexon, Inc. | 797.18M | 4.99% | 1,829,706 | - |
| 173 | ALMS | Alumis Inc. | 781.79M | 3.25% | 710,905 | 7.40M |
| 174 | RIGL | Rigel Pharmaceuticals, Inc. | 753.64M | -11.74% | 580,890 | 288.21M |
| 175 | DNA | Ginkgo Bioworks Holdings, Inc. | 749.50M | 11.75% | 2,092,128 | 130.75M |
| 176 | ARDX | Ardelyx, Inc. | 742.81M | -1.17% | 3,084,969 | 468.22M |
| 177 | OABI | OmniAb, Inc. | 739.51M | 4.97% | 828,688 | 40.21M |
| 178 | SLDB | Solid Biosciences Inc. | 735.51M | 6.63% | 914,926 | - |
| 179 | CGEM | Cullinan Therapeutics, Inc. | 734.29M | 5.65% | 412,198 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 729.07M | 0.41% | 1,046,092 | 181.72M |
| 181 | SANA | Sana Biotechnology, Inc. | 727.45M | 3.85% | 1,528,593 | - |
| 182 | NVCT | Nuvectis Pharma, Inc. | 701.69M | 12.78% | 165,561 | - |
| 183 | ATTO | Attovia Therapeutics, Inc. | 699.38M | 2.13% | 114,580 | 1.80M |
| 184 | SGMT | Sagimet Biosciences Inc. | 688.52M | 6.47% | 449,932 | - |
| 185 | FDMT | 4D Molecular Therapeutics, Inc. | 682.27M | 9.78% | 561,580 | 92.01M |
| 186 | ACHV | Achieve Life Sciences, Inc. | 680.70M | 3.76% | 632,593 | - |
| 187 | AURA | Aura Biosciences, Inc. | 680.30M | 3.47% | 377,763 | - |
| 188 | ZVRA | Zevra Therapeutics, Inc. | 680.14M | 8.55% | 974,730 | 147.76M |
| 189 | ANL | Adlai Nortye Group Ltd. | 679.40M | 8.99% | 484,098 | 18.06M |
| 190 | DBVT | DBV Technologies S.A. | 672.46M | 6.94% | 108,256 | 3.74M |
| 191 | AVBP | ArriVent BioPharma, Inc. | 672.06M | 11.45% | 1,007,418 | - |
| 192 | WVE | Wave Life Sciences, Inc. | 671.56M | 5.75% | 1,308,963 | 70.92M |
| 193 | IMMX | Immix Biopharma, Inc. | 670.68M | 12.36% | 987,086 | - |
| 194 | CADL | Candel Therapeutics, Inc. | 662.27M | 7.65% | 644,532 | - |
| 195 | HELP | Helus Pharma Inc. | 658.27M | 7.39% | 873,098 | - |
| 196 | GERN | Geron Corporation | 647.46M | 5.78% | 10,376,017 | 217.52M |
| 197 | DSGN | Design Therapeutics, Inc. | 638.97M | 5.59% | 182,147 | - |
| 198 | KURA | Kura Oncology, Inc. | 635.62M | 5.07% | 1,988,073 | 77.23M |
| 199 | APMD | Apnimed, Inc. | 630.29M | 6.92% | 105,822 | 115.12M |
| 200 | OLMA | Olema Pharmaceuticals, Inc. | 629.55M | 6.43% | 810,943 | - |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 599.02M | 7.06% | 2,521,590 | 6.40M |
| 202 | CBIO | Crescent Biopharma, Inc. | 588.94M | 6.34% | 65,474 | 11.88M |
| 203 | CLYM | Climb Bio, Inc. | 586.42M | 15.11% | 642,438 | - |
| 204 | BCAX | Bicara Therapeutics Inc. | 573.72M | 5.86% | 593,294 | - |
| 205 | FTH | Faeth Therapeutics, Inc. | 555.31M | 7.88% | 380,245 | - |
| 206 | OVID | Ovid Therapeutics Inc. | 550.74M | 9.30% | 2,527,692 | 1.58M |
| 207 | ENTX | Entera Bio Ltd. | 550.46M | 5.85% | 78,672 | 42.00K |
| 208 | VALN | Valneva SE | 547.35M | 0.62% | 4,108 | 163.30M |
| 209 | SRZN | Surrozen, Inc. | 538.85M | 6.21% | 68,846 | 11.51M |
| 210 | SLBT | SL Science Holding Limited | 538.05M | 4.82% | 29,750 | 3.27M |
| 211 | NGNE | Neurogene Inc. | 528.00M | 2.87% | 172,986 | 925.00K |
| 212 | CAPR | Capricor Therapeutics, Inc. | 521.51M | 4.30% | 3,199,529 | 11.13M |
| 213 | DMAC | DiaMedica Therapeutics Inc. | 518.23M | 6.31% | 98,759 | - |
| 214 | INDP | Indaptus Therapeutics, Inc. | 514.50M | 6.01% | 183,618 | - |
| 215 | RGNX | REGENXBIO Inc. | 503.02M | 3.25% | 681,412 | 153.91M |
| 216 | GYRE | Gyre Therapeutics, Inc. | 497.87M | 15.96% | 279,242 | 110.06M |
| 217 | ETRA | Electra Therapeutics, Inc. | 486.44M | 5.44% | 239,838 | - |
| 218 | MDXG | MiMedx Group, Inc. | 485.20M | 1.37% | 696,970 | 303.73M |
| 219 | MNPR | Monopar Therapeutics Inc. | 483.28M | 7.11% | 62,376 | - |
| 220 | CTMX | CytomX Therapeutics, Inc. | 480.47M | 3.04% | 1,907,496 | 14.03M |
| 221 | IAM | Iambic Therapeutics, Inc. | 463.58M | -15.98% | 544,062 | 18.25M |
| 222 | STTK | Shattuck Labs, Inc. | 455.65M | 1.11% | 628,235 | 1.00M |
| 223 | OCS | Oculis Holding AG | 454.97M | 7.91% | 266,248 | 1.12M |
| 224 | EPRX | Eupraxia Pharmaceuticals Inc. | 447.94M | 3.03% | 507,948 | - |
| 225 | PBYI | Puma Biotechnology, Inc. | 438.77M | -13.00% | 987,606 | 231.87M |
| 226 | BLSM | BlossomHill Therapeutics, Inc. | 433.99M | 10.56% | 111,939 | - |
| 227 | YDES | YD Bio Limited | 427.11M | -16.02% | 162,016 | 1.24M |
| 228 | ARVN | Arvinas, Inc. | 426.96M | -0.46% | 658,456 | 275.30M |
| 229 | ASMB | Assembly Biosciences, Inc. | 425.73M | 4.55% | 64,911 | 74.85M |
| 230 | RLMD | Relmada Therapeutics, Inc. | 421.88M | 4.91% | 707,114 | - |
| 231 | PHAT | Phathom Pharmaceuticals, Inc. | 414.63M | 2.76% | 1,333,375 | 274.88M |
| 232 | PRTA | Prothena Corporation plc | 411.72M | 1.65% | 209,068 | 52.74M |
| 233 | CRMD | CorMedix Inc. | 411.16M | 0.86% | 1,018,582 | 462.25M |
| 234 | ZURA | Zura Bio Limited | 406.01M | 13.31% | 1,790,226 | - |
| 235 | TECX | Tectonic Therapeutic, Inc. | 400.96M | 5.61% | 231,508 | - |
| 236 | ALT | Altimmune, Inc. | 393.90M | 2.79% | 1,600,761 | 31.00K |
| 237 | AGMB | AgomAb Therapeutics NV | 393.49M | 14.63% | 62,541 | - |
| 238 | EDIT | Editas Medicine, Inc. | 390.09M | -0.39% | 1,300,694 | 47.01M |
| 239 | RZLT | Rezolute, Inc. | 388.12M | 1.65% | 801,513 | - |
| 240 | CCCC | C4 Therapeutics, Inc. | 383.22M | 5.59% | 2,065,480 | 32.28M |
| 241 | CTNM | Contineum Therapeutics, Inc. | 382.45M | 10.56% | 197,372 | - |
| 242 | MPLT | MapLight Therapeutics, Inc. | 378.47M | 9.49% | 249,322 | - |
| 243 | PRLD | Prelude Therapeutics Incorporated | 377.48M | 3.09% | 84,094 | 22.42M |
| 244 | AVTX | Avalo Therapeutics, Inc. | 374.34M | 5.28% | 583,837 | 59.00K |
| 245 | LYEL | Lyell Immunopharma, Inc. | 366.08M | -0.73% | 164,092 | 15.00K |
| 246 | ALLO | Allogene Therapeutics, Inc. | 355.86M | -5.50% | 9,610,285 | 4.64M |
| 247 | FENC | Fennec Pharmaceuticals Inc. | 349.97M | 6.28% | 84,930 | 59.22M |
| 248 | IRD | Opus Genetics, Inc. | 348.59M | 4.62% | 451,243 | 9.86M |
| 249 | TRXB | TRex Bio, Inc. | 347.83M | -0.54% | 124,255 | - |
| 250 | PROK | ProKidney Corp. | 346.16M | 7.51% | 665,108 | 818.00K |
| 251 | AUTL | Autolus Therapeutics plc | 342.02M | 1.98% | 974,989 | 117.39M |
| 252 | OBIO | Orchestra BioMed Holdings, Inc. | 342.00M | 1.25% | 1,177,427 | 31.98M |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 341.67M | 0.95% | 85,627 | - |
| 254 | ALEC | Alector, Inc. | 338.77M | 9.33% | 635,186 | 173.47M |
| 255 | ASPE | Aspen Neuroscience, Inc. | 338.18M | -1.11% | 101,583 | - |
| 256 | OCGN | Ocugen, Inc. | 328.04M | 18.41% | 5,135,708 | 4.78M |
| 257 | EIKN | Eikon Therapeutics, Inc. | 327.70M | 3.60% | 270,096 | - |
| 258 | BNTC | Benitec Biopharma Inc. | 324.76M | 7.75% | 41,524 | - |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 322.68M | 2.93% | 291,232 | 16.96M |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 321.54M | 9.52% | 135,388 | 65.26M |
| 261 | AGEN | Agenus Inc. | 313.34M | 8.07% | 596,471 | 133.95M |
| 262 | GALT | Galectin Therapeutics Inc. | 308.60M | 2.51% | 167,073 | - |
| 263 | VCRE | Vicore Pharma Holding AB (publ) | 302.56M | 3.90% | 11,597 | 383.48K |
| 264 | IPSC | Century Therapeutics, Inc. | 302.40M | 10.60% | 1,576,927 | 109.16M |
| 265 | SCTX | Scribe Therapeutics Inc. | 301.11M | 2.75% | 236,565 | 33.30M |
| 266 | KYTX | Kyverna Therapeutics, Inc. | 300.56M | 5.42% | 601,985 | - |
| 267 | ARCT | Arcturus Therapeutics Holdings Inc. | 295.32M | 11.00% | 441,803 | 30.51M |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 287.86M | 5.12% | 3,654,244 | 424.00K |
| 269 | DTIL | Precision BioSciences, Inc. | 287.18M | 4.15% | 758,921 | 45.04M |
| 270 | FULC | Fulcrum Therapeutics, Inc. | 283.83M | 1.09% | 551,515 | 80.00M |
| 271 | QTTB | Q32 Bio Inc. | 275.96M | 4.75% | 123,403 | 53.74M |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 274.93M | 4.86% | 160,880 | 1.00 |
| 273 | SABS | SAB Biotherapeutics, Inc. | 273.87M | 2.38% | 187,754 | 114.70K |
| 274 | RCKT | Rocket Pharmaceuticals, Inc. | 272.24M | 1.85% | 757,021 | - |
| 275 | TTRX | Turn Therapeutics Inc. | 266.90M | 0.22% | 57,573 | - |
| 276 | VOGX | Vogenx, Inc. | 264.72M | -2.25% | 51,307 | - |
| 277 | VTVT | vTv Therapeutics Inc. | 264.15M | -2.21% | 8,177 | 36.84M |
| 278 | SPRY | ARS Pharmaceuticals, Inc. | 261.55M | -0.75% | 3,207,663 | 122.14M |
| 279 | CUVL | Clinuvel Pharmaceuticals Limited | 260.77M | 1.79% | 3,593 | 65.05M |
| 280 | LCTX | Lineage Cell Therapeutics, Inc. | 259.23M | 4.26% | 693,075 | 13.08M |
| 281 | BCYC | Bicycle Therapeutics plc | 256.54M | 5.17% | 163,128 | 83.53M |
| 282 | LRMR | Larimar Therapeutics, Inc. | 255.22M | 5.39% | 733,260 | - |
| 283 | EVMN | Evommune, Inc. | 244.25M | 5.65% | 238,542 | 10.00M |
| 284 | CAMP | Camp4 Therapeutics Corporation | 241.34M | 3.38% | 60,744 | 5.32M |
| 285 | ABEO | Abeona Therapeutics Inc. | 240.17M | 7.42% | 583,808 | 25.52M |
| 286 | LXEO | Lexeo Therapeutics, Inc. | 239.56M | 0.52% | 693,942 | - |
| 287 | VNDA | Vanda Pharmaceuticals Inc. | 232.20M | 6.96% | 562,527 | 229.28M |
| 288 | IMRX | Immuneering Corporation | 230.56M | 5.64% | 430,185 | - |
| 289 | KRRO | Korro Bio, Inc. | 229.87M | 5.97% | 59,870 | 1.29M |
| 290 | GLSI | Greenwich LifeSciences, Inc. | 228.10M | 6.08% | 56,582 | - |
| 291 | FATE | Fate Therapeutics, Inc. | 227.66M | 2.70% | 1,299,932 | 4.75M |
| 292 | RNAC | Cartesian Therapeutics, Inc. | 224.04M | 9.22% | 51,641 | 1.03M |
| 293 | ACIU | AC Immune SA | 219.73M | 4.74% | 151,046 | 23.75M |
| 294 | CABA | Cabaletta Bio, Inc. | 218.71M | 0.78% | 1,760,807 | - |
| 295 | ELDN | Eledon Pharmaceuticals, Inc. | 214.25M | 7.07% | 455,838 | - |
| 296 | PLX | Protalix BioTherapeutics, Inc. | 207.47M | 2.59% | 142,952 | 80.62M |
| 297 | DRUG | Bright Minds Biosciences Inc. | 204.90M | 11.79% | 133,323 | - |
| 298 | ARTV | Artiva Biotherapeutics, Inc. | 204.36M | 1.21% | 630,764 | 251.00K |
| 299 | PALI | Palisade Bio, Inc. | 200.41M | -0.86% | 1,407,015 | 500.00K |
| 300 | PYXS | Pyxis Oncology, Inc. | 200.17M | 4.08% | 368,470 | 11.04M |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 199.71M | -3.19% | 17,709 | 1.80M |
| 302 | KROS | Keros Therapeutics, Inc. | 193.12M | 3.07% | 101,238 | 40.76M |
| 303 | PRQR | ProQR Therapeutics N.V. | 189.81M | 1.13% | 244,101 | 21.05M |
| 304 | CGEN | Compugen Ltd. | 186.61M | 2.60% | 136,615 | 74.00M |
| 305 | IFRX | InflaRx N.V. | 184.21M | -7.75% | 788,794 | -38.53K |
| 306 | ACOG | Alpha Cognition Inc. | 181.85M | 2.45% | 85,220 | 15.26M |
| 307 | MDWD | MediWound Ltd. | 178.68M | 3.83% | 39,506 | 11.86M |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 176.16M | 2.32% | 103,966 | 7.15M |
| 309 | UPB | Upstream Bio, Inc. | 175.82M | - | 725,552 | 3.16M |
| 310 | IVVD | Invivyd, Inc. | 170.96M | -0.85% | 1,423,550 | 58.37M |
| 311 | TRDA | Entrada Therapeutics, Inc. | 169.29M | 3.19% | 313,450 | 3.98M |
| 312 | PEPG | PepGen Inc. | 167.95M | 4.53% | 682,171 | - |
| 313 | ZNTL | Zentalis Pharmaceuticals, Inc. | 167.10M | 3.22% | 844,773 | 26.87M |
| 314 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 165.16M | -5.07% | 250,138 | - |
| 315 | ORMP | Oramed Pharmaceuticals Inc. | 161.40M | -0.26% | 44,457 | 2.00M |
| 316 | STRO | Sutro Biopharma, Inc. | 159.93M | 4.84% | 101,320 | 45.70M |
| 317 | CNTN | Canton Strategic Holdings, Inc. | 159.36M | 3.63% | 563,872 | 1.50M |
| 318 | ANTX | AN2 Therapeutics, Inc. | 154.34M | 3.41% | 143,891 | - |
| 319 | MGNX | MacroGenics, Inc. | 154.15M | 9.01% | 295,170 | 175.14M |
| 320 | MSLE | Satellos Bioscience Inc. | 151.85M | 11.02% | 190,029 | - |
| 321 | SION | Sionna Therapeutics, Inc. | 148.52M | 0.15% | 631,256 | - |
| 322 | RNA | Atrium Therapeutics, Inc. | 144.54M | 1.56% | 69,910 | 35.84M |
| 323 | ALXO | ALX Oncology Holdings Inc. | 143.81M | -9.57% | 328,638 | - |
| 324 | NGEN | NervGen Pharma Corp. | 141.93M | - | 359,385 | - |
| 325 | YARW | Yarrow Bioscience, Inc. | 141.71M | 11.99% | 180,423 | - |
| 326 | TARA | Protara Therapeutics, Inc. | 137.69M | 9.39% | 408,830 | - |
| 327 | IPHA | Innate Pharma S.A. | 134.47M | 2.14% | 3,979 | 11.21M |
| 328 | CUE | Cue Biopharma, Inc. | 134.39M | 2.72% | 167,061 | 37.66M |
| 329 | ADAG | Adagene Inc. | 134.29M | -0.99% | 125,073 | 9.29M |
| 330 | CMPX | Compass Therapeutics, Inc. | 133.86M | 8.57% | 1,054,239 | 850.00K |
| 331 | SPRB | Spruce Biosciences, Inc. | 132.49M | 7.94% | 37,885 | 697.00K |
| 332 | VRXA | Veraxa Biotech AG | 131.75M | -2.15% | 125,852 | 29.54K |
| 333 | NKTX | Nkarta, Inc. | 126.06M | 12.10% | 952,939 | - |
| 334 | MENS | Jyong Biotech Ltd. | 123.97M | 1.21% | 23,939 | - |
| 335 | MOLN | Molecular Partners AG | 123.23M | - | 18 | 856.30K |
| 336 | INO | Inovio Pharmaceuticals, Inc. | 123.04M | -17.93% | 33,449,930 | 65.34K |
| 337 | PYPD | PolyPid Ltd. | 122.68M | 6.53% | 153,604 | - |
| 338 | ARMP | Armata Pharmaceuticals, Inc. | 120.47M | 8.00% | 31,478 | 5.54M |
| 339 | VYGR | Voyager Therapeutics, Inc. | 120.15M | 13.37% | 596,916 | 25.11M |
| 340 | HUMA | Humacyte, Inc. | 120.06M | 9.28% | 4,383,591 | 2.12M |
| 341 | CHRS | Coherus Oncology, Inc. | 118.16M | 2.12% | 789,947 | 50.94M |
| 342 | ENGN | enGene Therapeutics Inc. | 117.95M | 4.76% | 1,261,760 | - |
| 343 | CDXS | Codexis, Inc. | 117.72M | 5.39% | 222,058 | 77.68M |
| 344 | EQ | Equillium, Inc. | 115.98M | 11.28% | 154,455 | 4.39M |
| 345 | FHTX | Foghorn Therapeutics Inc. | 111.05M | -1.84% | 773,329 | 36.74M |
| 346 | NERV | Minerva Neurosciences, Inc. | 110.06M | 0.22% | 187,367 | - |
| 347 | OKUR | OnKure Therapeutics, Inc. | 109.76M | 7.33% | 345,047 | - |
| 348 | ANIX | Anixa Biosciences, Inc. | 108.46M | 2.97% | 86,635 | - |
| 349 | IMUX | Immunic, Inc. | 107.38M | 7.51% | 132,328 | - |
| 350 | AVXL | Anavex Life Sciences Corp. | 106.60M | 3.60% | 641,235 | - |
| 351 | OTLK | Outlook Therapeutics, Inc. | 105.83M | -1.00% | 1,279,903 | -1.16M |
| 352 | NBP | NovaBridge Biosciences | 104.24M | -1.05% | 365,820 | - |
| 353 | LENZ | LENZ Therapeutics, Inc. | 103.85M | 9.80% | 364,084 | 12.36M |
| 354 | MIST | Milestone Pharmaceuticals Inc. | 103.70M | 6.27% | 410,869 | 2.34M |
| 355 | HURA | TuHURA Biosciences, Inc. | 103.24M | 0.62% | 306,236 | - |
| 356 | NRXP | NRx Pharmaceuticals, Inc. | 101.24M | 3.08% | 461,007 | 3.39M |
| 357 | BDTX | Black Diamond Therapeutics, Inc. | 100.83M | 5.72% | 334,923 | 70.00M |
| 358 | UNCY | Unicycive Therapeutics, Inc. | 98.61M | 1.72% | 396,461 | - |
| 359 | TENX | Tenax Therapeutics, Inc. | 97.67M | 4.60% | 510,465 | - |
| 360 | KZIA | Kazia Therapeutics Limited | 97.02M | 1.14% | 130,432 | 1.27M |
| 361 | VANI | Vivani Medical, Inc. | 95.61M | 1.91% | 194,560 | - |
| 362 | PMVP | PMV Pharmaceuticals, Inc. | 95.52M | -0.78% | 150,722 | - |
| 363 | SEER | Seer, Inc. | 93.02M | 3.07% | 89,553 | 14.22M |
| 364 | RTSN | Retension Pharmaceuticals, Inc. | 91.31M | 2.24% | 23,767 | - |
| 365 | PLYX | Polaryx Therapeutics, Inc. | 91.22M | 5.17% | 21,005 | - |
| 366 | NMRA | Neumora Therapeutics, Inc. | 91.20M | -0.33% | 434,203 | - |
| 367 | ICCC | ImmuCell Corporation | 90.37M | - | 6,460 | 30.68M |
| 368 | PDSB | PDS Biotechnology Corporation | 89.14M | 5.13% | 2,324,697 | - |
| 369 | TLSA | Tiziana Life Sciences Ltd | 87.69M | 10.40% | 214,475 | - |
| 370 | GNLX | Genelux Corporation | 87.61M | 7.42% | 211,519 | 8.00K |
| 371 | CBUS | Cibus, Inc. | 86.36M | -0.88% | 42,277 | 4.35M |
| 372 | CLLS | Cellectis S.A. | 86.21M | 5.83% | 17,865 | 63.82M |
| 373 | RLYB | Rallybio Corporation | 84.26M | -0.25% | 16,803 | 434.00K |
| 374 | TNXP | Tonix Pharmaceuticals Holding Corp. | 82.15M | 4.13% | 497,365 | 29.10M |
| 375 | TNYA | Tenaya Therapeutics, Inc. | 80.85M | 14.10% | 2,702,883 | 3.03M |
| 376 | NTHI | NeOnc Technologies Holdings, Inc. | 80.78M | 1.56% | 132,615 | 39.99K |
| 377 | NRXS | NeurAxis, Inc. | 79.49M | 3.60% | 155,245 | 5.32M |
| 378 | TVGN | Tevogen Inc. | 78.84M | -9.89% | 3,673 | - |
| 379 | ATRA | Atara Biotherapeutics, Inc. | 78.29M | -2.01% | 8,908 | 6.19M |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 75.27M | 4.61% | 379,067 | 4.88M |
| 381 | OKYO | OKYO Pharma Limited | 72.95M | -0.71% | 62,867 | - |
| 382 | CNXU | Conexeu Sciences Inc. | 71.84M | 9.91% | 103,696 | - |
| 383 | MNOV | MediciNova, Inc. | 71.37M | - | 9,383 | 920.48K |
| 384 | COYA | Coya Therapeutics, Inc. | 69.44M | 5.34% | 172,706 | 8.02M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 69.42M | 3.18% | 269,305 | - |
| 386 | NTRB | Nutriband Inc. | 67.59M | -0.27% | 10,494 | 1.62M |
| 387 | CSBR | Champions Oncology, Inc. | 67.51M | 1.89% | 3,787 | 60.66M |
| 388 | CGTX | Cognition Therapeutics, Inc. | 64.45M | 6.66% | 211,028 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 63.93M | 1.06% | 225,509 | - |
| 390 | CING | Cingulate Inc. | 62.24M | 0.94% | 59,234 | - |
| 391 | FBIO | Fortress Biotech, Inc. | 61.70M | 0.54% | 108,034 | 68.47M |
| 392 | CRDF | Cardiff Oncology, Inc. | 61.04M | 3.88% | 250,535 | 508.00K |
| 393 | GOSS | Gossamer Bio, Inc. | 60.80M | 5.52% | 64,117 | 53.29M |
| 394 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 60.34M | 9.09% | 332,032 | - |
| 395 | SPRO | Spero Therapeutics, Inc. | 60.27M | 1.47% | 164,808 | 47.00M |
| 396 | KLRS | Kalaris Therapeutics, Inc. | 57.85M | 2.97% | 164,674 | - |
| 397 | XBIT | XBiotech Inc. | 57.01M | - | 19,877 | - |
| 398 | XLO | Xilio Therapeutics, Inc. | 56.98M | 1.88% | 3,461 | 64.09M |
| 399 | HRTX | Heron Therapeutics, Inc. | 55.95M | 5.25% | 816,736 | 151.18M |
| 400 | BOLD | Boundless Bio, Inc. | 55.73M | 1.66% | 63,597 | - |
| 401 | CLNN | Clene Inc. | 55.01M | -2.52% | 29,289 | 238.00K |
| 402 | VRCA | Verrica Pharmaceuticals Inc. | 54.97M | 3.56% | 156,775 | 30.32M |
| 403 | ONCY | Oncolytics Biotech Inc. | 54.87M | -4.12% | 384,316 | - |
| 404 | ALPS | Alps Group Inc | 53.66M | 2.61% | 395,630 | 3.74M |
| 405 | INKT | MiNK Therapeutics, Inc. | 53.38M | 4.08% | 6,453 | - |
| 406 | TELO | Telomir Pharmaceuticals, Inc. | 52.78M | -8.10% | 146,432 | - |
| 407 | RNTX | Rein Therapeutics Inc. | 51.71M | -2.06% | 331,692 | - |
| 408 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.94M | -1.41% | 13,155 | - |
| 409 | RNXT | RenovoRx, Inc. | 50.32M | -6.30% | 1,518,677 | 1.98M |
| 410 | PLRX | Pliant Therapeutics, Inc. | 49.93M | -1.16% | 116,712 | - |
| 411 | HYFT | MindWalk Holdings Corp. | 49.33M | 4.70% | 146,900 | 11.57M |
| 412 | HOWL | Werewolf Therapeutics, Inc. | 48.60M | -1.96% | 123,922 | 21.00M |
| 413 | IBIO | iBio, Inc. | 48.24M | 2.74% | 209,391 | 100.00K |
| 414 | TIL | Instil Bio, Inc. | 47.20M | -0.43% | 95,039 | - |
| 415 | IMA | ImageneBio, Inc. | 46.60M | -1.44% | 1,126 | 800.00K |
| 416 | CNTB | Connect Biopharma Holdings Limited | 46.16M | 0.18% | 228,334 | 2.95M |
| 417 | CRBU | Caribou Biosciences, Inc. | 45.75M | 3.49% | 1,083,614 | 9.44M |
| 418 | ATHE | Alterity Therapeutics Limited | 45.70M | 9.46% | 12,012 | 2.50M |
| 419 | MREO | Mereo BioPharma Group plc | 44.71M | -0.14% | 478,056 | 500.00K |
| 420 | GANX | Gain Therapeutics, Inc. | 44.08M | 5.16% | 270,388 | - |
| 421 | ATNM | Actinium Pharmaceuticals, Inc. | 44.02M | 7.69% | 71,483 | 35.09M |
| 422 | DWTX | Dogwood Therapeutics, Inc. | 42.49M | 20.19% | 127,296 | 100.00K |
| 423 | APLM | Apollomics, Inc. | 41.75M | 11.96% | 13,649 | 8.84M |
| 424 | OSTX | OS Therapies Incorporated | 41.59M | -8.15% | 812,828 | - |
| 425 | LONA | LeonaBio, Inc. | 41.27M | 0.92% | 45,456 | - |
| 426 | BMEA | Biomea Fusion, Inc. | 40.47M | -4.94% | 1,551,229 | - |
| 427 | ALDX | Aldeyra Therapeutics, Inc. | 40.07M | 7.84% | 415,793 | - |
| 428 | EXOZ | eXoZymes, Inc. | 39.54M | 3.65% | 10,754 | -700.00 |
| 429 | GRCE | Grace Therapeutics, Inc. | 39.34M | 5.06% | 91,603 | - |
| 430 | HYPD | Hyperion DeFi, Inc. | 38.23M | -3.91% | 342,499 | 1.40M |
| 431 | ELTX | Elicio Therapeutics, Inc. | 37.85M | 2.86% | 597,611 | - |
| 432 | PMN | ProMIS Neurosciences, Inc. | 37.64M | 14.99% | 336,307 | - |
| 433 | PTHS | Pelthos Therapeutics Inc. | 36.56M | 2.69% | 12,225 | 43.30M |
| 434 | VERU | Veru Inc. | 36.15M | 2.91% | 96,661 | 16.89M |
| 435 | BCTX | BriaCell Therapeutics Corp. | 35.02M | 21.71% | 133,980 | - |
| 436 | GRDX | GridAI Technologies Corp. | 34.66M | 4.82% | 48,669 | - |
| 437 | NNVC | NanoViricides, Inc. | 34.60M | 5.09% | 102,935 | - |
| 438 | IBO | Impact BioMedical Inc. | 34.53M | -8.14% | 1,615 | 35.00K |
| 439 | ANVS | Annovis Bio, Inc. | 34.52M | 21.11% | 8,134,674 | - |
| 440 | INMB | INmune Bio Inc. | 34.44M | -4.68% | 594,940 | 50.00K |
| 441 | SER | Serina Therapeutics, Inc. | 34.29M | -18.18% | 419,806 | 130.00K |
| 442 | ACET | Adicet Bio, Inc. | 33.26M | 5.82% | 131,559 | - |
| 443 | IRLA | IRulya Therapeutics Inc. | 31.57M | 5.90% | 17,518 | - |
| 444 | LITS | Lite Strategy, Inc. | 30.86M | 4.41% | 148,210 | - |
| 445 | EYPT | EyePoint, Inc. | 30.57M | -0.37% | 4,120,357 | 2.79M |
| 446 | EDSA | Edesa Biotech, Inc. | 29.05M | 0.94% | 27,316 | - |
| 447 | PLRZ | Polyrizon Ltd. | 28.07M | -0.26% | 5,082 | - |
| 448 | MGX | Metagenomi Therapeutics, Inc. | 26.54M | -3.87% | 310,586 | 13.56M |
| 449 | AARD | Aardvark Therapeutics, Inc. | 25.82M | 6.31% | 127,698 | - |
| 450 | RNAZ | TransCode Therapeutics, Inc. | 25.40M | -0.66% | 9,844 | - |
| 451 | BYSI | BeyondSpring Inc. | 25.33M | -2.59% | 28,624 | 1.88M |
| 452 | ALGS | Aligos Therapeutics, Inc. | 25.29M | -10.20% | 86,593 | 31.52M |
| 453 | IMMP | Immutep Limited | 24.70M | 14.68% | 37,534 | 13.79M |
| 454 | ABVC | ABVC BioPharma, Inc. | 24.69M | -2.07% | 15,025 | 797.92K |
| 455 | CELU | Celularity Inc. | 24.66M | 4.78% | 48,961 | 18.67M |
| 456 | CVM | CEL-SCI Corporation | 24.18M | 0.36% | 23,585 | - |
| 457 | NXTC | NextCure, Inc. | 23.62M | 0.78% | 41,614 | - |
| 458 | EVAX | Evaxion A/S | 23.57M | 2.41% | 133,404 | 7.49M |
| 459 | CRVO | CervoMed Inc. | 21.92M | - | 541,410 | 331.30K |
| 460 | ATOS | Atossa Therapeutics, Inc. | 21.66M | 7.43% | 30,308 | - |
| 461 | BSEM | BioStem Technologies, Inc. | 21.35M | 10.47% | 82,855 | 34.59M |
| 462 | FLNA | Filana Therapeutics, Inc. | 20.79M | -4.57% | 534,899 | - |
| 463 | IGC | IGC Pharma, Inc. | 20.76M | 6.24% | 386,479 | 1.11M |
| 464 | MCRB | Seres Therapeutics, Inc. | 20.64M | -1.67% | 65,513 | 2.13M |
| 465 | COCP | Cocrystal Pharma, Inc. | 19.84M | 3.00% | 15,998 | 330.00K |
| 466 | KTTA | Pasithea Therapeutics Corp. | 18.34M | 5.54% | 310,829 | - |
| 467 | QNTM | Quantum BioPharma Ltd. | 18.21M | 1.90% | 33,216 | - |
| 468 | JSPR | Jasper Therapeutics, Inc. | 18.07M | 15.73% | 54,966 | - |
| 469 | CNTX | Context Therapeutics Inc. | 18.00M | 4.26% | 1,212,209 | - |
| 470 | AKTX | Akari Therapeutics, Plc | 17.28M | -2.45% | 48,189 | - |
| 471 | ACTU | Actuate Therapeutics, Inc. | 17.13M | -4.74% | 420,974 | - |
| 472 | ESLA | Estrella Immunopharma, Inc. | 16.97M | -4.88% | 58,178 | - |
| 473 | QNRX | Quoin Pharmaceuticals, Ltd. | 16.81M | -9.09% | 23,050 | - |
| 474 | BOLT | Bolt Biotherapeutics, Inc. | 16.75M | 1.57% | 116,142 | 4.70M |
| 475 | ABOS | Acumen Pharmaceuticals, Inc. | 15.69M | 1.45% | 1,527,829 | - |
| 476 | ATYR | aTyr Pharma, Inc. | 15.62M | 5.64% | 40,129 | 190.00K |
| 477 | NCEL | NewcelX Ltd. | 15.60M | -6.57% | 9,561 | - |
| 478 | ALLR | Allarity Therapeutics, Inc. | 15.39M | -0.86% | 55,903 | 345.00K |
| 479 | KYNB | Kyntra Bio, Inc. | 15.39M | 3.83% | 8,714 | 4.62M |
| 480 | MRKR | Marker Therapeutics, Inc. | 15.27M | 2.26% | 45,317 | 3.55M |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 14.88M | -0.72% | 14,007 | 1.17M |
| 482 | PLUR | Pluri Inc. | 14.69M | 0.01% | 1,936 | 1.02M |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 14.67M | -4.15% | 153,987 | 7.11M |
| 484 | BCDA | BioCardia, Inc. | 13.50M | 0.21% | 121,026 | 3.00K |
| 485 | LPCN | Lipocine Inc. | 13.03M | 3.27% | 397,893 | 3.74M |
| 486 | DARE | Daré Bioscience, Inc. | 12.64M | 2.96% | 41,980 | 1.37M |
| 487 | PASG | Passage Bio, Inc. | 12.58M | 13.01% | 14,122 | - |
| 488 | GUTS | Fractyl Health, Inc. | 12.31M | 3.59% | 73,141 | 3.00K |
| 489 | DYAI | Dyadic International, Inc. | 12.24M | -1.21% | 64,309 | 3.80M |
| 490 | TCRX | TScan Therapeutics, Inc. | 12.21M | -0.94% | 222,325 | 7.11M |
| 491 | TVRD | Tvardi Therapeutics, Inc. | 12.21M | 5.85% | 39,992 | - |
| 492 | CLRB | Cellectar Biosciences, Inc. | 11.72M | 7.83% | 56,980 | - |
| 493 | PBM | Psyence Biomedical Ltd. | 11.58M | 3.23% | 23,318 | - |
| 494 | PTN | Palatin Technologies, Inc. | 11.53M | 10.86% | 22,410 | 13.19M |
| 495 | PPBT | Purple Biotech Ltd | 11.16M | 6.40% | 27,876 | - |
| 496 | HIND | Vyome Holdings, Inc. | 11.02M | -3.68% | 15,475 | 129.73K |
| 497 | RADX | Radiopharm Theranostics Limited | 10.49M | 15.86% | 64,545 | 8.90M |
| 498 | ICU | SeaStar Medical Holding Corporation | 10.10M | - | 43,550 | 1.71M |
| 499 | AZR | Azora Therapeutics, Inc. | 10.00M | 2.70% | 34,771 | - |
| 500 | BIVI | BioVie Inc. | 9.96M | 9.09% | 149,438 | - |